DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/grw4x7/selfinjectable) has announced the addition of the "Self-injectable Specialty Drugs to 2022" report to their offering. Increases in life expectancy are expected to result in a growing number of patients diagnosed with chronic conditions. To counteract the financial and logistical implications of this trend, pressure from public health and managed care organizations will place a premium on therapeutic
| < Prev | Next > |
|---|
